InDex Pharmaceuticals Holding AB (publ) Stock Nasdaq Stockholm
Equities
SE0008966295
Pharmaceuticals
Sales 2024 * | - | Sales 2025 * | - | Capitalization | 218M 2.35B 297M |
---|---|---|---|---|---|
Net income 2024 * | -259M -2.79B -353M | Net income 2025 * | -221M -2.38B -301M | EV / Sales 2024 * | - |
Net Debt 2024 * | 86.32M 931M 118M | Net Debt 2025 * | 306M 3.3B 417M | EV / Sales 2025 * | - |
P/E ratio 2024 * |
-0.83
x | P/E ratio 2025 * |
-1
x | Employees | - |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 62.47% |
Managers | Title | Age | Since |
---|---|---|---|
Jenny Sundqvist
CEO | Chief Executive Officer | 53 | 22-12-31 |
Johan Gileus
DFI | Director of Finance/CFO | 59 | 17-04-30 |
Charlotte Admyre
CTO | Chief Tech/Sci/R&D Officer | 45 | - |
Members of the board | Title | Age | Since |
---|---|---|---|
Uli Alf Hacksell
BRD | Director/Board Member | 74 | 15-12-31 |
Director/Board Member | 68 | 10-12-31 | |
Chairman | 72 | 10-12-31 |
1st Jan change | Capi. | |
---|---|---|
+31.17% | 588B | |
-3.42% | 364B | |
+18.02% | 326B | |
+4.27% | 285B | |
+14.94% | 239B | |
+9.89% | 210B | |
-7.69% | 200B | |
+8.12% | 167B | |
-1.42% | 161B |